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Summary
Objectives: A collagen scaffold has been long used in order to enhance the regeneration of articular cartilage. In the present study, we inves-
tigate the effectiveness of a concentration-gradient (CG) collagen that is designed to recruit efﬁciently the mesenchymal stem cells (MSCs) to
the central region of the full-thickness cartilage defects via haptotaxis.
Methods: The present study used Cellmatrix (0.3% type I collagen; Nitta gelatin, Osaka, Japan) as the collagen material. We prepared
33%CG collagen gel and 50%CG collagen gel. No gradient collagen gel served as negative control. Full-thickness cartilage defects were cre-
ated at the patella groove of the rabbit knee, to which the three different collagen gels were transplanted. Bromodeoxyuridine (BrdU) positive,
proliferating cells were enumerated and localized, whereas the histological grading score for cartilage regeneration was counted. The expres-
sion of type I and type II collagens was evaluated by immunohistochemistry. We also conﬁrmed that the MSCs migrate toward the collagen
substrate of higher concentration in a stringently in vitro haptotactic manner.
Results: Enumeration of the BrdU-positive cells demonstrated that 33%CG collagen gel recruited a signiﬁcantly larger number of proliferating
cells to the central region of the cartilage defect. The histological grading score for the regenerated cartilage treated with 33%CG collagen gel
was superior to the other groups.
Conclusions: CG collagen scaffold recruits effectively the MSCs to the center of full-thickness cartilage defect and enhances regeneration of
the full-thickness cartilage defect.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The poor healing potential of articular cartilage has been
a well-known concern in orthopedic surgery1. The partial
chondral defects often display little healing. In turn, osteo-
chondral full-thickness defects that penetrate the subchon-
dral bone are ﬁlled by ﬁbrocartilaginous or ﬁbrous tissue2.
Small full-thickness defects (3 mm in diameter) spontane-
ously regenerate the surfacing articular cartilage concomi-
tantly with repair of the subchondral bone through migration
and differentiation of mesenchymal progenitor cells3.
However, large full-thickness defects (>5 mm in diameter)
result in ﬁbrous tissue4.
Local application of exogenous collagen has been known
to promote repair of damaged cartilage, although it does not
always warrant regeneration of hyaline cartilage5e7. Fur-
thermore, the autologous chondrocyte implantation (ACI)8
combined with the use of several types of collagen scaffold,
namely gels9,10 and membranesdmatrix-induced autolo-
gous chondrocyte implantation (MACI)11dhas been re-
ported. Our previous studies revealed that the exogenous*Correspondence and reprint requests to: Tomohiro Mimura,
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1083collagen gel recruits the mesenchymal stem cells (MSCs)
to the defect. It also demonstrated that the cultured MSCs
were recruited to the substrate-bound collagen gel in a clear
dose-dependent manner in an in vitro migration assay12.
Several composite collagen substrates, seeded with cul-
tured autologous chondrocytes on their porous side, have
been manufactured in order to mimic the normal osteochon-
dral structure, e.g., a layered composite of type I/III colla-
gens: Chondro-Gide (Geistlich Biomaterials, Wolhusen,
Switzerland)13 and two-layered type I collagen matrix: Inte-
gra (Integra LifeScience, Plainsboro, USA)14. However,
there has been no study using collagen composite in order
to manipulate cell kinetics for the cartilage repair. The pres-
ent study attempted to promote recruitment, the MSCs to
the central region of the cartilage defect by manufacturing
concentration-gradient (CG) collagen scaffold. We evalu-
ated the usefulness of the CG collagen gel for the treatment
of osteochondral full-thickness defects based on the hy-
pothesis that CG collagen gel recruits successfully the
MSCs to the center of full-thickness defect by the gradient
effect.Materials and methodsANIMAL AND COLLAGENFifty-eight Japanese white rabbits weighing 2.5e2.99 kg (approximately
13 weeks old, Kitayama labes, Nagano, Japan) were used. Type I collagen
1084 T. Mimura et al.: Concentration-gradient collagen for cartilage repair(0.3% Cellmatrix I-A, Nitta Gelatin, Osaka, Japan) was manufactured from
the dermis of porcine tendon via pepsin treatment. Cellmatrix I-A is puriﬁed
under the acid condition and its ﬁnal concentration is adjusted to result in the
0.3% acid-soluble type I collagen solution. Each collagen gel was fabricated
by mixing with type I collagen solution, 10 concentrated phosphate buffered
saline (PBS), and the reconstituted buffer (2.2 g NaHCO3 and 4.77 g
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) in 100 ml
of 0.05 N NaOH).
We prepared two different CG collagen gels (Fig. 1). The whole size of
collagen gel was 5 mm in diameter and 5 mm in height. The 33%CG collagen
gel was fabricated by inserting 0.24% collagen gel to the center of the 0.18%
collagen gel. The size of central gel was 2.4 mm in diameter and 3 mm in
height. The 50%CG collagen gel was likewise fabricated by inserting 0.27%
collagen gel to the center of the 0.18% collagen gel (Fig. 1). No gradient
collagen gel was fabricated using 0.18% collagen gel only, and this non-
composite conventional collagen gel was transplanted as negative control.SCANNING ELECTRON MICROSCOPIC (SEM) STUDYThe non-composite 0.18%, 0.24% and 0.27% collagen gels as well as the
50%CG collagen were incubated for 1 h with 2.5% glutaraldehyde solution in
0.1 M PBS at 4C. The gels were treated with 1% OsO4 in 0.1 M PBS at 4C
for 1.5 h and replaced by 3-methylbutyl acetate at room temperature after
dehydration. After absolute drying by Critical Point Dryer (Hitachi, Tokyo,
Japan), the specimens were coated by Ion Coater (Eiko Engineering, Ibaraki,
Japan). The specimens were then studied under SEM (S-570: Hitachi,
Tokyo, Japan).IN VITRO MIGRATION ASSAYFig. 2. In vitro cell migration assay. Schema of cell migration assay.
Surfaces A and B are coated with different concentration of colla-
gen (0e100 times gradient), and the number of migration cells on
surface B is counted.We revealed that cultured MSCs were recruited to the substrate-bound
collagen gel in a clear dose-dependent manner in vitro migration assay in
a previous study12. We investigated the optimal CG for migration of MSCs
with different collagen concentration in a similar in vitro setting.
MSCs were taken from the Japanese white rabbits. Brieﬂy, the proximale
medial surface of each tibia was exposed through a small incision and 2 ml
of intramedullary ﬂuid was aspirated from the bone marrow of tibia11 with use
of an 18-G needle that was fastened to a 10 ml syringe containing 0.1 ml of
heparin (3000 units/ml). The aspirate was washed twice with Tyrode balanced
solution (Sigma, St Louis, MO, USA) and centrifuged at 180 times gravity for
5 min. According to Wakitani’s protocol for isolation of MSCs10, middle layer
between the top clear layer and under blood cell layer was aspirated and
resuspended in Doulbecco’s modiﬁed Eagle medium (DMEM) containing
10% fetal bovine serum (FBS).
Migration assays were performed using Transwell Permeable Supports
(Corning, MA, USA) (Fig. 2). The bottom of the upper well consists of
polyester membrane with 8 mm pore. To this migration assay system,
we applied the same collagen material used in the in vivo assay. The up-
per surface of the membrane (surface A) was coated with 0.0001% colla-
gen. The lower surface of the membrane (surface B) was coated with
different concentration of collagen: (1) surface A: 0.0001% vs surface B:
0.0001% (0 gradient), (2) surface A: 0.0001% vs surface B: 0.001% (10
times gradient), (3) surface A: 0.0001% vs surface B: 0.003% (30 times
gradient), (4) surface A: 0.0001% vs surface B: 0.005% (50 times gradi-
ent), and (5) surface A: 0.0001% vs surface B: 0.01% (100 times
gradient).Fig. 1. Fabrication of the CG collagen gel. The 33%CG collagen gel
and 50%CG collagen gel are fabricated by inserting the central col-
lagen to the 0.18% collagen, the inserted central collagen is 0.24%
and 0.27%, respectively. The inserted cylinder is 2.4 mm in diame-
ter and 3 mm in height, and the whole size is 5 mm in diameter and
5 mm in height.We investigated the migration activities of the MSCs in response to the
CG. The upper wells were ﬁlled with 1.5 105 cells/1.5 ml of FBS-free
DMEM. The lower wells were ﬁlled with FBS-free DMEM. The chamber
was incubated for 5 h in a humidiﬁed incubator at 37C. After the migration
of cells, the membranes were removed, then ﬁxed with 4% paraformalde-
hyde, and stained with toluidine blue. The membranes were subsequently
placed onto grass slides, and the number of migration cells on surface B
was counted by light microscopy at 200-fold magniﬁcation. For each tripli-
cate, the number of cells in 10 microscope ﬁelds was determined and the
mean was calculated.ARTICULAR CARTILAGE DEFECT MODELThe rabbits were anesthetized by intramuscular injection of a mixture of
ketamine hydrochloride (60e70 mg/kg) and xylazine (6 mg/kg) at the time
of surgery. After removal of the hair, an incision was made at the anterome-
dial aspect of the knee, and the joint was exposed. Full-thickness defect
(5 mm in diameter and 5 mm in depth) was created on the patellar groove
using an electric drill equipped with a 5 mm diameter drill bit (Fig. 3). The
defects were randomly transplanted with three different collagen gels. For
the cell source, the present model depends on the migration of cells from
the subchondral bone marrow and, the collagen gels were transplanted to
the defects while bleeding from bone marrow. After the transplantation, the
capsule and subcutaneous incision were sutured. Rabbits were allowed to
move freely after operation. We investigated 111 defects (ﬁve cases of
patella dislocations were excluded).TISSUE PREPARATIONThe rabbits were killed with an overdose of sodium pentobarbital at the
postoperative weeks 1 (n¼ 9), 2 (n¼ 10), 3 (n¼ 9), 4 (n¼ 10), 8 (n¼ 10)
and 12 (n¼ 10). One shot of 10 mM bromodeoxyuridine (BrdU) was injected
intravenously 1 h before the sacriﬁce15,16. The entire knee was dissected
and distal part of the femur was then extirpated. Each experimental knee
was obtained at the postoperative week 1 (non-composite collagen: n¼ 6,
33%CG collagen: n¼ 6, 50%CG collagen: n¼ 6), week 2 (n¼ 6, n¼ 7,
n¼ 6, respectively), week 3 (all specimens: n¼ 6), week 4 (n¼ 6, n¼ 6,
n¼ 7, respectively), week 8 (all specimens: n¼ 6), and week 12 (n¼ 6,
n¼ 7, n¼ 6, respectively).
The specimens were ﬁxed in 20% formalin at room temperature for 2
days, decalciﬁed with 10% ethylenediamine tetra-acetic (EDTA) for 8 weeks,
and then embedded in parafﬁn. Each specimen was cut into 3 mm axial
section and deparafﬁnized, dehydrated, and used for subsequent staining,
Fig. 3. Articular cartilage defect model. Full-thickness cartilage de-
fect, 5 mm in diameter and 5 mm in depth, was created on the pa-
tellar groove. The bleeding from subchondral bone marrow was
observed.
Fig. 4. The central and peripheral regions for localization of prolifer-
ating cells. The distribution of proliferating cells is identiﬁed by BrdU
technique. The central and peripheral regions are indicated by the
12 gray rectangles and 12 white rectangles, respectively. The
BrdU-positive cell number is counted at a magniﬁcation of 200.
Table I
Histological grading scale for the defects of cartilage
1085Osteoarthritis and Cartilage Vol. 16, No. 9toluidine blue, BrdU, and immunohistochemical staining of type I and II
collagens.Surface regularity*
Smooth (>3/4) 0
Moderate (>1/2e3/4) 1
Irregular (1/4e1/2) 2PROLIFERATIVE CELL NUMBER ENGAGED IN THE REPAIR
TISSUE
Severely irregular (<1/4) 3
Thickness of cartilagesy
>2/3 0
1/3e2/3 1
<l/3 2
Integration of donor with host adjacent cartilage
Both edges integrated 0
One edge integrated 1
Neither edge integrated 2
Cell morphology
Hyaline cartilage 0
Mostly hyaline cartilage 1
Mostly ﬁbrocartilage 2
Mostly non-cartilage 3
Non-cartilage only 4
Matrix-staining (metachromasia)For the immunostaining of BrdU, endogenous peroxidase activity was
blocked by 0.3% hydrogen peroxide. Antigen retrieval was done by heating
with 0.01 M sodium citrate buffer (pH 6.0) and treating with 0.05 mg protease
type XXIV (Sigma, St Louis, MO, USA) in 0.1 ml PBS. Nonspeciﬁc staining
was blocked by incubation with 10% normal pig serum (KHOJIN BIO,
Saitama, Japan) in PBS. The sections were incubated with a monoclonal
mouse anti-BrdU antibody (Bection Dickinson, San Jose, CA, USA), diluted
1:500 with PBS, at 4C overnight. Antibody binding was visualized by
incubating with biotinylated rabbit anti-mouse IgG (Dako Cytomation,
Glostrup, Denmark) and peroxidase-conjugated streptavidin in combination
with diaminobenzidine (DAB) solution. The sections were then counter-
stained with methyl green.
Proliferating cell number was counted using the section stained with
BrdU. The defect was subdivided into the central region and peripheral
region (Fig. 4). The central region was deﬁned as 2.4 mm in width and
2.0 mm in depth, and the peripheral region consisted of the region surround-
ing the central region. Both regions were divided into 12 sub-regions for
detailed enumeration of the cells. The positive cell number was counted at
a magniﬁcation of 200.Normal (compared with host
adjacent cartilage)
0
Slightly reduced 1IMMUNOHISTOCHEMICAL STAININGMarkedly reduced 2
No metachromatic stain 3
Total maximum 14
*Total smooth area of the reparative cartilage compared with the
entire area of the cartilage defect.
yAverage thickness of the reparative cartilage compared with
that of the surrounding cartilage.The expression of type I and II collagens in the reparative tissue was stud-
ied immunohistochemically. We used a mouse monoclonal antibody against
human type I and type II collagens that has been veriﬁed to crossreact with
rabbit type I and type II collagens (Daiichi Fine Chemical, Toyama, Japan).
For the immunohistochemical staining, endogenous peroxidase activity
was blocked by 0.3% hydrogen peroxide. The sections were incubated
with the antibody against type I collagen (diluted 1:200 with Tris Buffer sa-
line) or with the antibody against type II collagen (diluted 1:5000 with Tris
Buffer saline), at 4C overnight. Antibody binding was visualized by incubat-
ing with Histoﬁne Simple Stain kit (Nichirei bioscience, Tokyo, Japan) incombination with DAB solution. The sections were then counterstained
with hematoxylin.HISTOLOGICAL EXAMINATION OF REPAIR TISSUEThe parafﬁn sections were stained with toluidine blue and were histolog-
ically evaluated by a blind observer using Wakitani’s histological grading
scale (Table I)17. In the Wakitani’s grading scale, the repair tissue is eval-
uated for cell morphology, matrix-staining, surface regularity, thickness of
cartilage and integration of donor with host cartilage. Total point 14
1086 T. Mimura et al.: Concentration-gradient collagen for cartilage repairrepresents the worst score, while the point 0 means the normal hyaline
cartilage.STATISTICAL ANALYSISResults were expressed as mean values standard deviation (SD). A
one-way analysis of variance (ANOVA) with a Bonferroni/Dunn post hoc
test was used to determine signiﬁcant differences among groups. P value
of less than 0.05 was considered to be signiﬁcant.ResultsEVALUATION OF COLLAGEN GELSFig. 6. Histograms showing the results of in vitro cell migration as-
say. The 30 times gradient generates the most effective migration
activity for the cultured MSCs. Asterisks (*) indicate signiﬁcant dif-
ference vs 0 gradient (P< 0.0001). Double asterisk (**) indicates
signiﬁcant difference vs 0 gradient (P ¼ 0.0001). Data are ex-
pressed as meanSD.SEM revealed that the porosity of the ﬁbrillar network de-
creased in proportion to the collagen concentration, though
the diameter of the each ﬁber was not altered between each
collagen concentration [Fig. 5(A)e(C)]. The SEM of the
50%CG collagen demonstrated that the density of the ﬁbril-
lar network increased stepwise from 0.18% to 0.27% at their
interface [Fig. 5(D)]. The SEM also conﬁrmed that the ﬁbril-
lar networks of both concentrations were closely connected
with each other.IN VITRO MIGRATION ASSAYThe in vitro migration assay using MSCs revealed re-
markable cell kinetics in response to the collagen gradient
(Fig. 6). Practically no migration occurred in the experimen-
tal condition where both the surfaces A and B were coated
with 0.0001% collagen (no gradient condition). In turn, the
number of the cells migrated to the surface B increased in
a good accordance with the gradient increase until the 30
times gradient. However, the cell migration activity became
less prominent when the collagen gradient was higher than
the 30 times, forming a peak migration activity therein. In
another word, the 30 times gradient generated the most
effective in vitro migration activity in a haptotactic manner.
The migration activity of the MSCs in the 100 times gradi-
ent returned to the similar level to that of the 10 times
gradient.Fig. 5. Evaluation of collagen gels by SEM. (A), (B), and (C) are 0.18% co
(A)e(C) The density of collagen network increases in proportion to the co
0.18% collagen and lower right is 0.27% collagen. The ﬁbrillar networks o
broken line). (A)e(C): bar is 2HISTOLOGICAL FINDINGS AND COUNTING OF BRDU-POSITIVE
CELLS IN THE REPAIR TISSUEOne-week postoperatively, the cartilage defect was ﬁlled
by ﬁbrin network, the ﬁbrous strands of which formed super-
ﬁcially an arc passing from on edge of the defect to the
other. However, there was no cartilage like tissue in the
central region. Numerous BrdU-positive cells were ob-
served in the peripheral region, but not in the central region
of the defect. These ﬁndings were equally observed, irre-
spective of the three different experimental conditions.
Two-week postoperatively, the transplanted collagen was
partially absorbed, and the experimental conditions dis-
played characteristic distribution of the BrdU-positive cells
(Fig. 7). In the non-composite collagen, which served as neg-
ative control, only small number of BrdU-positive cells were
localized in the central region [Fig. 7(C)], but numerous
BrdU-positive cells remained in the peripheral region of the
cartilage defect [Fig. 7(B)]. The 33%CG collagen, in contrast,
displayed a distinctive distribution pattern. There were morellagen gel, 0.24% collagen gel and 0.27% collagen gel, respectively.
llagen concentration. (D) Indicates a 50%CG collagen: left upper is
f 0.18% and 0.27% collagen are connected with each other (white
0 mm. (D): bar is 80 mm.
Fig. 7. Proliferating cells in the repair tissue at the second week. BrdU staining of the samples treated with non-composite 0.18% collagen (A),
33%CG collagen (D) and 50%CG collagen (G). The rectangles in panels (A), (D) and (G) are magniﬁed in panels (B, C), (E, F) and (H, I),
respectively. Panels (B), (E), (H) represent peripheral region of (A), (D), (G), respectively and panels (C), (F), (I) represent central region. Nu-
merous BrdU-positive cells are revealed in the central and peripheral region of 33%CG collagen (E, F), but only small numbers of BrdU-
positive cells are localized in the central region of the non-composite 0.18% collagen (C) and 50%CG collagen (I) (magniﬁcation for (A),
(D) and (G): 40).
1087Osteoarthritis and Cartilage Vol. 16, No. 9BrdU-positive cells than in any other collagens [Fig. 7(D)],
and numerous BrdU-positive cells were revealed in both
the central and peripheral regions [Fig. 7(E) and (F)]. The
50%CG collagen demonstrated a similar distribution pattern
of the BrdU-positive cells to the non-composite collagen
[Fig. 7(H) and (I)]. In the peripheral region at 2 weeks postop-
eratively, similar number of BrdU-positive cellswere counted.
Three-week postoperatively, the process of the cartilage
regeneration appeared to go on further, and the density of
the BrdU-positive cells decreased in both the central and
peripheral regions. The decrease of the BrdU-positive cells
was uniformly observed in each experimental condition.SPATIOTEMPORAL DISTRIBUTION OF THE BrdU-POSITIVE
CELLS IN CONTROL GROUPAlong the time course, there were marked changes in the
densities of the BrdU-positive cells distributed in theperipheral and central regions of the control (non-composite
collagen) [Fig. 8(A)]. At the ﬁrst week, a large number of the
BrdU-positive cells were noted in the peripheral region, im-
plicating the MSCs recruitment from the surrounding bone
marrow. The number of the BrdU-positive cells in the central
region was by far smaller than that of the peripheral region,
suggesting that bone marrow-derived MSCs have not yet
reached to the central region.
At the second week, the number of the BrdU-positive
cells in the peripheral region decreased from that of the ﬁrst
week. Interestingly, the number of the BrdU-positive cells
increased in the central region, suggesting that a group of
the BrdU-positive cells were recruited from the peripheral
to the central region. At the third week, the number of the
BrdU-positive cells in both the peripheral and central re-
gions decreased. This observation is consistent with our hy-
pothesis that the BrdU-positive MSCs lost their proliferative
activity in parallel to their cell migration and differentiation.
Fig. 8. Histograms showing the proliferating cells in the repair tis-
sue. (A) Distribution of the BrdU-positive cells in control group
(non-composite 0.18% collagen). (B) The results of BrdU-positive
cells in central region at the second week. (C) The results of
BrdU-positive cells in peripheral region at the third week. White
bars, Gray bars and black bars present non-composite 0.18% col-
lagen, 33%CG collagen, and 50%CG collagen, respectively. (A)
The ﬁrst week was characterized by the MSCs recruitment to the
peripheral region from the surrounding bone marrow. (B) In the cen-
tral region at the second week, numerous BrdU-positive cells are
recruited in the 33%CG collagen. (C) In turn, in the peripheral re-
gion at the third week, the least number of BrdU-positive cells are
observed in the 33%CG collagen. The statistical signiﬁcance of as-
terisk (*) and double asterisks (**) is P< 0.05 and P< 0.01, respec-
tively. Data are expressed as meanSD.
1088 T. Mimura et al.: Concentration-gradient collagen for cartilage repairTaken together, the ﬁrst week was characterized by the
MSCs recruitment to the peripheral region from the sur-
rounding bone marrow, while the second week by the shift
of the MSCs from the peripheral to the central region. Fi-
nally, the recruited MSCs lost their proliferative activity at
the third week, suggesting that they may have differentiated
into the non-proliferating terminal stage.SPATIOTEMPORAL DISTRIBUTION OF THE
BrdU-POSITIVE CELLS IN CG COLLAGEN GELSIn the control non-composite collagen gel, the second
week was characterized by the shift of the MSCs from the
peripheral to the central regions [Fig. 8(A)]. Interestingly,
the number of BrdU-positive cells recruited in the centralregions was the largest in the 33%CG collagen [*,
P< 0.05, Fig. 8(B)], suggesting that the 33%CG collagen
promoted the sequential shift of the cell distribution from
the peripheral to the central region and most effectively re-
cruited the MSCs to the central region.
In the control non-composite collagen, the recruited
MSCs lost their proliferative activity during the third week,
perhaps reﬂecting the cell differentiation [Fig. 8(A)]. The
number of BrdU-positive cells in the peripheral region was
the smallest in the 33%CG collagen [**, P< 0.01,
Fig. 8(C)], suggesting that the recruited MSCs in the
33%CG collagen effectively differentiated into the non-
proliferating terminal stage.IMMUNOHISTOCHEMICAL STAININGThe previous study has demonstrated that the initial pro-
duction of the cartilage matrix takes place at the fourth
week, followed by the gradual maturation of the cartilage
until the eighth week12. The present study, thus, compared
the eighth week samples to evaluate efﬁcacy of the CG col-
lagen (Fig. 9).
In the non-composite collagen, type II collagen was par-
tially and weakly stained in the peripheral region, and type
I collagen was observed in the central and peripheral re-
gions [Fig. 9(A) and (D)]. In the 33%CG collagen, in turn,
type II collagen was strongly and widely stained in both
the regions, and type I collagen was weakly stained in the
central region [Fig. 9(B) and (E)]. In the 50%CG collagen,
type II collagen was strongly stained but it was absent
from the central region [Fig. 9(C)]. The type I collagen
was present, though weak, in the central region of the
cartilage defect, where the type II collagen should prevail
[arrow, Fig. 9(F)].HISTOLOGICAL ASSESSMENT ON THE EFFECT OF GRADIENT
COLLAGENGlycosaminoglycan of extracellular matrix was evaluated
by toluidine blue staining of the regenerated tissue (Fig. 10).
In the non-composite 0.18% collagen, ﬁbrous and/or ﬁbro-
cartilaginous tissue was demonstrated in the central region,
and peripheral metachromasia was weak [Fig. 10(A)]. The
strong and uniform metachromasia was observed in the
33%CG collagen [black arrow, Fig. 10(B)]. In the 33%CG
collagen, the morphology of regenerated matrices and cells
was like that of the hyaline cartilage. In 50%CG collagen,
there was a central cleft in the regenerated tissue, and
the metachromasia was less prominent in the central region
[Fig. 10(C)]. The regenerated tissue in the central region of
the 50%CG collagen was mostly ﬁbrocartilage [white arrow,
Fig. 10(C)].HISTOLOGICAL SCALE (WAKITANI SCALE)The repaired tissues were histologically evaluated using
Wakitani’s histological grading scale at the fourth, eighth
and 12th week samples (Fig. 11). The Wakitani’s histologi-
cal grading scale scores the better cartilage with smaller
number. In general, the histological quality of the repaired
tissue improved until the 12th week, though each score of
the fourth and eighth weeks was similar. At all the studied
time points, the histological score of 33%CG collagen was
the best of all experimental conditions. The signiﬁcant differ-
ences existed between the non-composite collagen and
33%CG collagen at the fourth and eighth weeks (P< 0.05).
Fig. 9. Immunohistochemical staining speciﬁc for type I collagen and type II collagen at the eighth week. The sections are stained with the
antibody against type II collagen (A)e(C), and the antibody against type I collagen (D)e(F). (A, D), (B, E) and (C, F) is transplanted with
non-composite 0.18% collagen, 33%CG collagen, and 50%CG collagen, respectively. In the 33%CG collagen gel, type II collagen is strongly
stained in the central and peripheral regions, but type I collagen is weakly stained in the central region. The type I collagen is present in the
central region in 50%CG collagen (arrow) (magniﬁcation: 20).
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Collagen gels have been used in both in vitro and in vivo
experiments for cartilage regeneration18e27, and some have
been already applied for clinical cases9,10,28e30. For in-
stance, CaReS (rat tail type I collagen gel: Ars Artho, Es-
sligen, Germany) has been tried for clinical cartilage repair
of the knee in Germany9, and Cellmatrix (porcine tendon
type I collagen gel) has been used for cartilage repair in
Japan28,30. Gavenis et al.31 referred to the probable superi-
ority of collagen gel to collagen sponge or membrane in
dealing with deep cartilage defects. However, the detailed
mechanism of cartilage repair by collagen gel has remained
unidentiﬁed.
In our previous study, we have demonstrated that exoge-
nous collagen gel effectively recruited proliferating cells toFig. 10. Histological examination of repair tissue at the eighth week. (
33%CG collagen and 50%CG collagen, respectively. The strong me
ﬁbrocartilage is demonstrated in the central region of the non-compos
blue; magniﬁcatthe cartilage defect, a major of which were from bone mar-
row. An accumulating number of studies have attempted to
isolate by using cell surface marker, and suggested that the
BrdU-positive, CD44-positive and CD45-negative are most
effectively represent MSCs32. Since most of these cells
were BrdU-positive, CD44-positive and CD45-negative12,
a majority of the cells recruited into the exogenous collagen
gel were conﬁrmed to be the bone marrow-derived MSCs.
MSC enables its life time-lasting renewal by the vast ca-
pacity for proliferation, whereas the terminally differentiated
cells, i.e., osteoblast, chondrocyte, or neuron, do not pos-
sess ability to divide33. During the chondrogenic differentia-
tion, motile precursors of chondrocyte retain limited capacity
to divide but their major commitment is to ﬁnd the way to the
target substrate33. In agreement with this hypothesis, our
previous in vitro migration assay demonstrated that theA), (B) and (C) are treated with non-composite 0.18% collagen,
tachromasia is observed in 33%CG collagen (black arrow), but
ite 0.18% collagen and 50%CG collagen (white arrow) (toluidine
ion: 20).
Fig. 11. Histological score for the regeneration of full-thickness de-
fects using Wakitani’s histological grading score after the fourth
week. The defects are treated with three different collagen cylin-
ders: non-composite 0.18% collagen, 33%CG collagen, and
50%CG collagen. Histological score for the regeneration tissue is
evaluated after the fourth week. 33%CG collagen resulted in the
best score of all experimental conditions at the fourth, eighth, and
12th postoperative weeks. Asterisks (*) indicate signiﬁcant differ-
ence (P< 0.05). Data are expressed as mean SD.
1090 T. Mimura et al.: Concentration-gradient collagen for cartilage repairmarrow-derived MSCs behaved as the motile precursors of
chondrogenic differentiation. However, this motile precursor
of chondrocyte did not sufﬁciently migrate into the central re-
gion of the cartilage defect when the cartilage defects were
treated by the conventional non-composite collagen gels,
resulting in the incomplete regeneration of the cartilage12.
The present study succeeded in recruiting the chondrocyte
precursors to the central region by applying CG collagen
gel. Since the chondrocyte precursor migrated over the
boundary for higher concentration of collagen scaffold, we
believe that the mechanism of this migration by cellematrix
interaction is haptotaxis.
Haptotaxis was ﬁrst described by Carter34, and he sug-
gested that cell movement from a less adherent to a more
adherent surface was the dominant principle in tissue cell
motility. Keller et al.35 revealed that haptotaxis was themove-
ment along a gradient of increasing substrate adhesion. In
our study, the stepwise-haptotaxis of the collagen gel seems
to work only during ﬁrst 2 weeks. After 2 weeks, it is rationally
assumed that the recruited chondrocyte precursor further
enters the immotile phase to prepare for matrix-synthesis.
In our study, the 33%CG collagen gel enhanced cartilage
repair as compared to the non-composite collagen gel. How-
ever, we unexpectedly demonstrated the inferiority of
50%CG collagen compared with 33%CG collagen. The rea-
son for this unexpected ﬁnding seems to result from attenu-
ated cell motility induced by the 50% concentration increase.
The attenuated cell motility across the substrate gradient
higher than 50% concentration increase of 50%CG collagen
may implicate that the cells exposed to such high concentra-
tion of the target substrate loses their motility, and thereby
triggers to differentiate to the ﬁnal stage at wrong site.
The transition from the migratory precursors to the immo-
tile, matrix-producing chondrocyte may be manifested by
loss of cell motility. Indeed, the present in vitro migration
assay showed that cell motility induced by collagen gradient
exhibited a clear-cut peak [Fig. 2(B)]. These in vitro and
in vivo observations suggest that there is an optimal gradi-
ent when using the gradient collagen cylinder to augment
regeneration of full-thickness cartilage defect. A further ex-
amination for an ideal in vivo CG to enable the efﬁcient cell
recruitment is necessary for better regeneration of damaged
cartilage.In the present study, the full-thickness cartilage defect was
well regenerated using CG collagen at week 4 and 8. How-
ever, ﬁnal quality of the regenerated cartilage did not fulﬁll
the histological standard of hyaline cartilage at week 12
(Fig. 11). Chondrogenic lineage cells presumably exhibit
varying activities for cell proliferation depending on the stage
of differentiation. Numerous growth factors with potent
mitogenicity may not promote a functional differentiation
that must be linked to an escape from the cell cycle. The ter-
minal differentiation into the immotile, matrix-synthesizing
chondrocytes should take place to the chondrocyte precur-
sors upon reaching the target central region. We speculate
that the key to success of our strategy to cartilage repair is
the agent(s) that controls growth and differentiation of the
precursor cells. Therefore, after concentrating the chondro-
cyte precursors to the central region by the stepwise-
haptotaxis, timely application of the agent(s) that promote
the terminal differentiation into the immotile cells is warranted
to a successful management of injured cartilage.Conﬂict of interest
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